mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Brain Ischemia

mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin has been researched along with Brain Ischemia in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gupta, S; Sharma, SS	1

Other Studies

1 other study(ies) available for mn(iii) 5,10,15,20-tetrakis(n-methylpyridinium-2-yl)porphyrin and Brain Ischemia

Article	Year
Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation. European journal of pharmacology, 2007, Apr-30, Volume: 561, Issue:1-3 Topics: Animals; Brain Ischemia; Catalase; Disease Models, Animal; DNA Fragmentation; Gerbillinae; Hippocampus; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Malondialdehyde; Metalloporphyrins; Motor Activity; Neurons; Neuroprotective Agents; Oxidative Stress; Pyramidal Cells; Superoxide Dismutase	2007

Article

Year

Neuroprotective effect of MnTMPyP, a superoxide dismutase/catalase mimetic in global cerebral ischemia is mediated through reduction of oxidative stress and DNA fragmentation.

European journal of pharmacology, 2007, Apr-30, Volume: 561, Issue:1-3

Topics: Animals; Brain Ischemia; Catalase; Disease Models, Animal; DNA Fragmentation; Gerbillinae; Hippocampus; In Situ Nick-End Labeling; Lipid Peroxidation; Male; Malondialdehyde; Metalloporphyrins; Motor Activity; Neurons; Neuroprotective Agents; Oxidative Stress; Pyramidal Cells; Superoxide Dismutase

2007